Crossmark

TRIM9 and TRIM67 Are New Targets in Paraneoplastic Cerebellar Degeneration

Crossref DOI link: https://doi.org/10.1007/s12311-018-0987-5

Published Online: 2018-10-22

Published Print: 2019-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Do, Le Duy

Gupton, Stephanie L.

Tanji, Kunikazu

Bastien, Joubert

Brugière, Sabine

Couté, Yohann

Quadrio, Isabelle

Rogemond, Veronique

Fabien, Nicole

Desestret, Virginie

Honnorat, Jerome
Funding

Funding for this research was provided by:

Agence Nationale de la Recherche (ANR-14-CE15-0001-MECANO)

Agence Nationale de la Recherche (ANR-10-603 INBS-08-01)

Agence Nationale de la Recherche (ANR-10-LABX-49-01)

Fondation pour la recherche médicale (DQ20170336751)

Foundation for the National Institutes of Health (GM108970)
License Information

Text and Data Mining valid from 2018-10-22
More Information

Article History

First Online: 22 October 2018

Compliance with Ethical Standards

:

: The authors declare that they have no conflict of interest.